Digital Health, Drug Development and Trends

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Digital Health Global

MARCH 28, 2024

Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.

Drug Development

Drug Development Pharmaceuticals Digital Health

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

FEBRUARY 19, 2024

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

Pharmaceuticals

Pharmaceuticals Drug Development Leadership Digital Health

Digital Health Technologies in Clinical Trials

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.

Health Technology

Health Technology Digital Health Life Science BioTech

How Digital Health improves patient experiences in Alzheimer’s care

Digital Health Global

DECEMBER 5, 2023

Despite a history of drug development failures in the field, recent work provides reason for optimism, showing a possible therapeutic arsenal to limit disease progression at an early stage.

Patient Experience

Patient Experience Digital Health Drug Development Healthcare Innovation

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.

Pharmaceuticals

Pharmaceuticals Drug Development Digital Health

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

APRIL 5, 2024

Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies. Office Hours Call 1-917-300-0470 For U.S./

Drug Development

Drug Development Pharmaceuticals Digital Health Health Technology

Digital Healthcare Transformation: Improving Patient Experience and Outcomes

Digital Health Global

MAY 10, 2023

Enhancing outcomes for patients with the implementation of digital technologies, such as artificial intelligence (AI) and big data analysis, empowers healthcare professionals to make better-informed decisions. Artificial Intelligence is utilized in various areas of healthcare, ranging from drug development to medical image analysis.

Patient Experience

Patient Experience Mobile Health Telemedicine Drug Development

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. They can view historic data and forecast future trends.

Life Science

Life Science Digital Health Drug Development Patient Experience

Digital Health v HealthTech: What is the difference?

Lloyd Price

JULY 15, 2024

Exec Summary: Digital Health is a subset of Healthtech. Digital Health focuses on the individual patient, while Healthtech focuses on the entire healthcare ecosystem. Artificial intelligence: This is a rapidly developing field that has the potential to revolutionize healthcare. Subscribe Today!

Digital Health

Digital Health Mobile Health Telehealth Leadership

Vital Lines September 2023

Redox

SEPTEMBER 26, 2023

Top stories CMS creates all-payer model for states CMS is offering an all-payer funding opportunity of up to $12M for eight states to improve population health. Two trends might be changing the game for private clouds: 1) flat/increased pricing for the public cloud and 2) dropping data center costs.

FHIR

FHIR Drug Development Telehealth Digital Health

Key Themes from the Morgan Stanley 22nd Annual Global Healthcare Conference 2024

Lloyd Price

SEPTEMBER 16, 2024

Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Conference attendees discussed the latest trends in biopharma innovation, including gene therapy, cell therapy, and antibody-drug conjugates. Subscribe Today!

Digital Health

Digital Health Drug Development healthcare technology Leadership

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

DECEMBER 2, 2024

The increasing importance of digital health, coupled with abundant capital and supportive regulatory environments, is likely to drive continued M&A activity and higher valuations. Regulatory Environment: Favourable regulatory policies and increased government support for digital health initiatives are fostering innovation.

Mental health

Mental health Digital Health healthcare technology Telehealth

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

NOVEMBER 16, 2024

Merative's product portfolio will focus on six key areas: Health Insights: Providing actionable insights to improve healthcare delivery and decision-making. MarketScan: Offering comprehensive data on healthcare costs and utilisation trends. Subscribe Today!

Drug Development

Drug Development healthcare technology Leadership Life Science

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

FEBRUARY 22, 2024

Exec Summary: The pain management market is experiencing exciting growth, driven by several key trends: Increased Demand: Chronic pain prevalence: Chronic pain affects a significant portion of the population, with an aging demographic further increasing demand. Subscribe Today!

Pain management

Pain management Mental health Telehealth healthcare technology

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

OCTOBER 14, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Leadership

Leadership healthcare technology Digital Health Mental health

23andMe announces major Workforce Reduction amid Financial Struggles

Digital Health Global

NOVEMBER 12, 2024

These developments underscore the ongoing challenges and transformations in both the energy and biotechnology sectors, reflecting broader trends towards sustainability and financial stability. 23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research.

Pharmaceuticals

Pharmaceuticals BioTech Leadership Drug Development

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

JUNE 17, 2023

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

Digital Health

Digital Health Drug Development Telemedicine Telehealth

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

Healthcare IT Today

AUGUST 7, 2022

However, only 46% consider the information they send to the National Health Service to be secure, and only 40% would be willing to share information digitally with providers who aren’t part of the NHS system.

eCare

eCare Digital Health Drug Development Healthcare IT

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

NOVEMBER 8, 2024

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.

Digital Health

Digital Health healthcare technology Pharmaceuticals Telehealth

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Palantir's software is able to identify patterns and trends in data.

Drug Development

Drug Development Health science healthcare technology Leadership

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

NOVEMBER 2, 2023

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates.

Drug Development

Drug Development Pharmaceuticals Public Health Telehealth

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

MAY 6, 2020

Bardy Diagnostics is a digital health and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. And the list will continue to be updated over time.

Connected Health

Connected Health Telehealth Pharmaceuticals EHR

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024

Lloyd Price

AUGUST 7, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Interoperability

Interoperability Leadership EHR Drug Development

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

DECEMBER 2, 2024

Here are some key trends and developments to watch: Key Trends: Technological Advancements: New technologies are revolutionizing wound care, including advanced wound dressings, bioengineered skin substitutes, and innovative wound management devices. Subscribe Today!

Digital Health

Digital Health healthcare technology Telemedicine Leadership

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals

Pharmaceuticals Digital Health Drug Development Life Science

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

APRIL 22, 2024

These algorithms can analyse vast amounts of medical data, including patient history, lab results, imaging scans, and genetic information, to identify patterns and trends that would be difficult for humans to see. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Data analysis to identify trends and patterns, aiding in resource allocation.

healthcare technology

healthcare technology Leadership Drug Development Digital Health

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Interoperability

Interoperability healthcare technology HIPAA Leadership

What can Healthcare AI learn from Weather AI?

Lloyd Price

MAY 6, 2024

HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Healthcare AI can leverage similar techniques to analyse patient data and predict: Disease risks Potential complications Individual health trends This enables proactive interventions and personalised care plans.

healthcare technology

healthcare technology Leadership Drug Development Digital Health

The outlook for healthcare in 2022

Waracle

JANUARY 5, 2022

This trend initially picked up because of the pandemic, but it’s here to stay as a component of healthcare offerings for the convenience that it offers. The majority of respondents in our recent Patient Experience survey shared that they are happy to have online consultations about their health, except for things like physical injuries.

Patient Experience

Patient Experience Drug Development Digital Health Remote care

10 Key Variables in HealthTech M&A valuation multiples

Lloyd Price

SEPTEMBER 29, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Leadership

Leadership Drug Development healthcare technology Digital Health

Healthcare Interoperability and Cloud Services – 2025 Health IT Predictions

Healthcare IT Today

DECEMBER 31, 2024

Valerie Reich, VP of Healthcare Strategy at Hero Digital In 2025, healthcare will continue evolving into a connected network of services centered around the consumer. This collaboration will drive innovations such as faster drug development and coordinated patient care.

Interoperability

Interoperability Health IT Pharmaceuticals Digital Health

Connected Health Pulse

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Biofourmis announces major agreements with top pharmaceutical companies

Trending Sources

Digital Health Technologies in Clinical Trials

How Digital Health improves patient experiences in Alzheimer’s care

The next revolution in the pharmaceutical industry: the transformative potential of AI

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Healthcare Transformation: Improving Patient Experience and Outcomes

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health v HealthTech: What is the difference?

Vital Lines September 2023

Key Themes from the Morgan Stanley 22nd Annual Global Healthcare Conference 2024

Future HealthTech Valuations in 2025: A Dynamic Landscape

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

HLTH 2024: What are the key talking points likely to be?

23andMe announces major Workforce Reduction amid Financial Struggles

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

HealthTech M&A 2025 Predictions: Europe and USA

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

6 challenges healthtech can help us tackle – Pt.2

A guide to connected health device and remote patient monitoring vendors

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024

Wound Care: Emerging HealthTech market to watch in 2025

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

What can Healthcare AI learn from Weather AI?

The outlook for healthcare in 2022

10 Key Variables in HealthTech M&A valuation multiples

Healthcare Interoperability and Cloud Services – 2025 Health IT Predictions

Stay Connected